111 Capital’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
111 Capital's CL Position: Q2 2026 in Review
111 Capital reduced its Colgate-Palmolive (CL) stake by 42% in Q2 2026, selling an estimated $337K and leaving 5,397 shares worth $495K. The position accounts for 0.09% of the portfolio, ranked #239.
111 Capital first reported a position in CL in Q4 2024 and has held it in 6 quarters since. The position peaked at $878K in Q1 2025. 2,025 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- 111 Capital held 5,397 shares of Colgate-Palmolive worth $495K as of Q2 2026.
- 111 Capital sold 3,849 Colgate-Palmolive shares in Q2 2026, an estimated $337K.
- Colgate-Palmolive made up 0.09% of 111 Capital's portfolio in Q2 2026, its #239 holding.
- 111 Capital first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 6 quarters since.
- 111 Capital's Colgate-Palmolive position peaked at $878K in Q1 2025.
- 2,025 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.